Role of the Immune System in Preventing Laryngeal Cancer
ConditionHead & Neck Cancer
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorEuropean Institute of Oncology
About this trial
Laryngeal dysplasia and progression to carcinoma: investigating genetic and immune alterations predictive of malignant transformation
Eligibility criteria
Qualifiers
Histopathological diagnosis of laryngeal dysplasia.
Age >18 years and informed consent.
Disqualifiers
Prior surgical, radiotherapeutic, or oncologic treatments for head and neck regions.
Congenital or acquired immunodeficiency disorders.
Synchronous malignancies.
Immunosuppressive therapy.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov